Friday, April 15th, 2016

RnRMarketResearch adds Lung Cancer Market research to its database.

A&G Pharmaceutical, Inc., Abbott Diagnostics, Abcodia Ltd., Aberystwyth University, Advanced Marker Discovery, Advpharma Inc., Almac Diagnostics Limited, Armune BioScience, Inc., Aurelium BioPharma Inc., Biocept, Inc., Biodesix Inc., BioMark Diagnostics Inc., BioMark Technologies Inc., BioMarker Strategies, LLC, 5.15 Biomoda, Inc. (Inactive), BioNTech AG, BioSystems International, BioTime, Inc., Boise State University, Cancer Research Technology Limited, Cangen Biotechnologies, Inc., Celera Corporation, Cellanyx Diagnostics, Inc., CellMax Life , CeMines, Inc., Cepheid, Ceres Nanosciences, Inc., Cernostics Inc., ChemImage Corporation, Chronix Biomedical, Inc., Clarient, Inc., Courtagen Life Sciences, Inc., Dako A/S, Dartmouth College, XEPTAGEN SpA and Zetiq Technologies Ltd.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer diagnostic tests pipeline products.

Get sample copy of this research at


  • Extensive coverage of the Lung Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Lung Cancer diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Complete research report is available at

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Lung Cancer diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date


File Library

Contact Profile

RnR Market Research

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus:



RSS / Feeds:

Ritesh Tiwari
P: + 1 888 391 5441


Lung Cancer,Lung Cancer market,Lung Cancer pipeline,Lung Cancer industry,Lung Cancer market 2015




More Formats

View QR Code